远距药房市场：按服务（药房咨询、远端订单输入）、按最终用途（医院、初级保健中心）-COVID-19、俄罗斯-乌克兰衝突、高通膨的累积影响-2023-2030年全球预测

预计到 2023 年，全球远距药局市场规模将达到 10.4668 亿美元，年复合成长率为 10.01%，预计到 2030 年将以 20.4374 亿美元的惊人速度成长。

FPNV定位矩阵

FPNV定位矩阵对于评估全球远距药局市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 全球远距药局市场规模及预测是多少？

2.在预测期内，COVID-19 对全球远距药局市场的阻碍因素和影响为何？

3. 在预测期内，全球远距药局市场需要投资哪些产品/细分市场/应用/领域？

4. 远距药局在全球市场的竞争策略为何？

5. 全球远距药局市场的技术趋势和法律规范是什么？

6. 全球远距药局市场主要供应商的市占率是多少？

7. 哪些型态和策略性倡议被认为适合远距药局进入全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 远端医疗远端医疗及其日益增长的影响
    • 网路普及不断提高，网路使用者数量不断增加
    • 降低成本和提高营运效率的好处
  • 抑制因素
    • 有关远程药房的法规差异
  • 机会
    • 加大偏远地区取得基本药物的力度
    • 策略联盟，提供高效率的远距药局服务
  • 任务
    • 认知度低且基础设施支援有限
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章远距药局市场：依服务分类

• 药局咨询
• 远程订单输入

第7章远距药局市场：依最终用途

• 医院
• 初级保健中心

第8章美洲远距药局市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章亚太远距药局市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章欧洲、中东和非洲的远距药局市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第11章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

• 讨论指南
• 关于许可证和定价

The Global Telepharmacy Market is forecasted to grow significantly, with a projected USD 1,046.68 million in 2023 at a CAGR of 10.01% and expected to reach a staggering USD 2,043.74 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Telepharmacy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Telepharmacy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Services, market is studied across Pharmacy Consultation and Remote Order Entry. The Pharmacy Consultation is projected to witness significant market share during forecast period.

Based on End-Use, market is studied across Hospitals and Primary Care Centers. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Telepharmacy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Telepharmacy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Telepharmacy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Telepharmacy Market?

4. What is the competitive strategic window for opportunities in the Global Telepharmacy Market?

5. What are the technology trends and regulatory frameworks in the Global Telepharmacy Market?

6. What is the market share of the leading vendors in the Global Telepharmacy Market?

7. What modes and strategic moves are considered suitable for entering the Global Telepharmacy Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Telepharmacy Market, by Services, 2022 vs 2030
• 4.3. Telepharmacy Market, by End-Use, 2022 vs 2030
• 4.4. Telepharmacy Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising influence of telemedicine and telehealth
    • 5.1.1.2. Growth in internet penetration coupled with rising internet users
    • 5.1.1.3. Benefits of cost savings and operational efficiencies
  • 5.1.2. Restraints
    • 5.1.2.1. Differences in laws and regulations related to telepharmacy
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing approach to avail the essential drugs in remote areas
    • 5.1.3.2. Strategic alliances to provide efficient telepharmacy services
  • 5.1.4. Challenges
    • 5.1.4.1. Less awareness and limited infrastructure support
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Telepharmacy Market, by Services

• 6.1. Introduction
• 6.2. Pharmacy Consultation
• 6.3. Remote Order Entry

7. Telepharmacy Market, by End-Use

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Primary Care Centers

8. Americas Telepharmacy Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Telepharmacy Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Telepharmacy Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. TELEPHARMACY MARKET RESEARCH PROCESS
• FIGURE 2. TELEPHARMACY MARKET SIZE, 2022 VS 2030
• FIGURE 3. TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. TELEPHARMACY MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
• FIGURE 5. TELEPHARMACY MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
• FIGURE 6. TELEPHARMACY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. TELEPHARMACY MARKET DYNAMICS
• FIGURE 8. TELEPHARMACY MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. TELEPHARMACY MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. TELEPHARMACY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 5. TELEPHARMACY MARKET SIZE, BY PHARMACY CONSULTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. TELEPHARMACY MARKET SIZE, BY REMOTE ORDER ENTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 8. TELEPHARMACY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. TELEPHARMACY MARKET SIZE, BY PRIMARY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 11. AMERICAS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 12. AMERICAS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 13. ARGENTINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 14. ARGENTINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 15. BRAZIL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 16. BRAZIL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 17. CANADA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 18. CANADA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 19. MEXICO TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 20. MEXICO TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 21. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 22. UNITED STATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 23. UNITED STATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 26. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. AUSTRALIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 28. AUSTRALIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. CHINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 30. CHINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. INDIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 32. INDIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 33. INDONESIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 34. INDONESIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. JAPAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 36. JAPAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. MALAYSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 38. MALAYSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. PHILIPPINES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 40. PHILIPPINES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. SINGAPORE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 42. SINGAPORE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 44. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. TAIWAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. TAIWAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. THAILAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 48. THAILAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. VIETNAM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 50. VIETNAM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 53. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. DENMARK TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 55. DENMARK TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. EGYPT TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 57. EGYPT TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. FINLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 59. FINLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. FRANCE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 61. FRANCE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. GERMANY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 63. GERMANY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. ISRAEL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 65. ISRAEL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. ITALY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. ITALY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. NETHERLANDS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 69. NETHERLANDS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. NIGERIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 71. NIGERIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. NORWAY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 73. NORWAY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. POLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. POLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. QATAR TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 77. QATAR TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. RUSSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 79. RUSSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 81. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. SPAIN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 85. SPAIN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 86. SWEDEN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 87. SWEDEN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. SWITZERLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 89. SWITZERLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 90. TURKEY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 91. TURKEY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 93. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 95. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 97. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 98. TELEPHARMACY MARKET LICENSE & PRICING